Skip to main content
. 2017 Feb 9;101(6):791–802. doi: 10.1002/cpt.589

Figure 3.

Figure 3

Association of significant single‐nucleotide polymorphisms (a) rs4244285 in CYP2C19, also known as CYP2C19*2; (b) rs12456693 in SLC14A2; (c) rs2254638 in N6AMT1; and (d) rs2487032 in ABCA1 with pharmacokinetic (PK) parameters of clopidogrel and H4 in 31 patients with coronary heart disease. The PK parameters include area under the concentration‐time curve (AUC), peak concentration (Cmax), and peak concentration (Tmax).